Johnson & Johnson Stock Reacts to New Earnings Estimates and Job Cut Signal - ad-hoc-news.de
Article excerpt
Johnson & Johnson stock (ISIN US4781601046) is in investors' focus on September 21, 2026, primarily due to new analyst estimates and an announced job reduction. According to MarketBeat on September 21, 2026, Erste Group Bank has slightly raised its earnings forecast for fiscal year 2027 to 12.83 US dollars per share, which is significantly above the current consensus corridor of 11.61 US dollars per share. The analysis by Erste Group Bank confirms the positive fundamental stance towards Johnson & Johnson; the stock holds a Moderate Buy status in consensus and an average price target of 274.13 US dollars, as reported by MarketBeat on September 21, 2026. The same report highlights that Johnson & Johnson achieved earnings per share of 2.90 US dollars and revenue of 25.31 billion US dollars in the most recent quarter, thus exceeding expectations, as MarketBeat illustrates. A comparison to the consensus estimate shows the range of expectations: For the current year, an average earning of 11.61 US dollars per share is expected, while Erste Group Bank already anticipates 12.83 US dollars per share for 2027, which is about 1.22 US dollars more than the current annual consensus for 2026 according to MarketBeat. The positive assessment is based not only on the figures but also, in particular, on the broad portfolio in Pharma and MedTech, as well as the reliable dividend policy with a...
Keep reading with a free account
The rest of this article, and every signal for Johnson & Johnson, is in your free account.
Extracted from this sentence
As LatestLY reported on September 21, 2026, Johnson & Johnson Services has filed a notice under the US WARN Act and plans to eliminate a total of 87 positions at its New Brunswick, New Jersey location by December 18, 2026.
